---
figid: PMC8226607__cells-10-01402-g001
figtitle: 'Neuroprotection in Glaucoma: NAD+/NADH Redox State as a Potential Biomarker
  and Therapeutic Target'
organisms:
- NA
pmcid: PMC8226607
filename: cells-10-01402-g001.jpg
figlink: /pmc/articles/PMC8226607/figure/cells-10-01402-f001/
number: F1
caption: 'NAD+synthesis and catabolism. There are multiple routes to sustain NAD concentrations
  within the cell; de novo from tryptophan (Trp), through the Preiss–Handler pathway,
  or via nicotinamide (NAM) or nicotinamide riboside (NR) salvage pathways. Extracellular
  is shown to the left of the image, intracellular to the right. NAD+ consumption
  is shown in pink. Legend: Nicotinamide mononucleotide (NMN); extracellular nicotinamide
  phosphoribosyltransferase (eNAMPT); intracellular nicotinamide phosphoribosyltransferase
  (iNAMPT); nicotinate phosphoribosyltransferase (NAPRT); nicotinic acid mononucleotide
  (NAMN); quinolinate phosphoribosyltransferase (QPRT); nicotinic acid adenine dinucleotide
  (NAAD); nicotinamide riboside kinase 1 and 2 (NRK1–2); NAD+ synthase (NADS); NA
  phosphoribosyl–transferase (NAPRT); NAM mononucleotide transferases (NMNAT); poly(ADP–ribose)
  polymerases (PARP); sirtuins (SIRTs); Sterile alpha and TIR motif–containing 1 (SARM1);
  cyclic ADP–ribose synthases (cADPR).'
papertitle: 'Neuroprotection in Glaucoma: NAD+/NADH Redox State as a Potential Biomarker
  and Therapeutic Target.'
reftext: Bledi Petriti, et al. Cells. 2021 Jun;10(6):1402.
year: '2021'
doi: 10.3390/cells10061402
journal_title: Cells
journal_nlm_ta: Cells
publisher_name: MDPI
keywords: glaucoma | mitochondrial dysfunction | retinal ganglion cell (RGC) | nicotinamide
  adenine dinucleotide (NAD+) | NAD+/NADH redox state | ATP | neurodegenerative disease
automl_pathway: 0.9520927
figid_alias: PMC8226607__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC8226607__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8226607__cells-10-01402-g001.html
  '@type': Dataset
  description: 'NAD+synthesis and catabolism. There are multiple routes to sustain
    NAD concentrations within the cell; de novo from tryptophan (Trp), through the
    Preiss–Handler pathway, or via nicotinamide (NAM) or nicotinamide riboside (NR)
    salvage pathways. Extracellular is shown to the left of the image, intracellular
    to the right. NAD+ consumption is shown in pink. Legend: Nicotinamide mononucleotide
    (NMN); extracellular nicotinamide phosphoribosyltransferase (eNAMPT); intracellular
    nicotinamide phosphoribosyltransferase (iNAMPT); nicotinate phosphoribosyltransferase
    (NAPRT); nicotinic acid mononucleotide (NAMN); quinolinate phosphoribosyltransferase
    (QPRT); nicotinic acid adenine dinucleotide (NAAD); nicotinamide riboside kinase
    1 and 2 (NRK1–2); NAD+ synthase (NADS); NA phosphoribosyl–transferase (NAPRT);
    NAM mononucleotide transferases (NMNAT); poly(ADP–ribose) polymerases (PARP);
    sirtuins (SIRTs); Sterile alpha and TIR motif–containing 1 (SARM1); cyclic ADP–ribose
    synthases (cADPR).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NT5E
  - CD38
  - BST1
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - NAMPT
  - STAC3
  - NAPRT
  - QPRT
  - NMRK1
  - NEK4
  - NMRK2
  - NMNAT1
  - SARM1
  - na
  - nr
  - Parp
  - Naprt
  - Nmnat
  - Nadsyn
  - de
  - Sarm
---
